We report development of two additional vaccine candidates against types 1 and 3 poliovirus serotypes. The candidates were generated by replacing the capsid coding region of nOPV2 with those from Sabi
Polio vaccines are essential tools for prevention of poliomyelitis. However, the transmission and evolution of the oral polio vaccine (OPV) poses an obstacle to complete global eradication. Examining
